Rapid efficacy of a noradrenergic reuptake inhibitor in depression in advanced Parkinson's disease:: A double-blind, randomized, placebo-controlled study

被引：0
|
作者：
Devos, D.
Poirot, I.
Dujardin, K.
Duhem, S.
Lucas, B.
Waucquier, N.
Moreau, C.
Bocquillon, P.
Devos, P.
Ajebbar, K.
Thielemans, B.
Cottencin, O.
Thomas, P.
Destee, A.
Bordet, R.
Defebvre, L.
机构：
来源：
MOVEMENT DISORDERS | 2007年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
727
引用
收藏
页码：S223 / S224
页数：2
相关论文
共 50 条
  • [21] A Randomized, Double-Blind, Placebo-Controlled Trial of Levetiracetam for Dyskinesia in Parkinson's Disease
    Wong, Kitty K.
    Alty, Jane E.
    Goy, Amanda G.
    Raghav, Sanjay
    Reutens, David C.
    Kempster, Peter A.
    MOVEMENT DISORDERS, 2011, 26 (08) : 1552 - 1555
  • [22] A randomized double-blind placebo-controlled trial of probiotics for constipation in Parkinson's disease
    Chong, K. K.
    Lim, S. Y.
    Manap, M. A. A. A.
    Lim, J. L.
    Low, S. C.
    Mahadeva, S. K.
    Tan, A. H.
    MOVEMENT DISORDERS, 2018, 33 : S194 - S194
  • [23] Botulinum toxin type A for drooling in Parkinson's disease: A double-blind, randomized, placebo-controlled study
    Lagalla, Giovanni
    Millevolte, Marzia
    Capecci, Marianna
    Provinciali, Leandro
    Ceravolo, Maria Gabriella
    MOVEMENT DISORDERS, 2006, 21 (05) : 704 - 707
  • [24] Randomized double-blind placebo-controlled trial of hydrogen inhalation for Parkinson’s disease: a pilot study
    Asako Yoritaka
    Yasuko Kobayashi
    Tetsuo Hayashi
    Shinji Saiki
    Nobutaka Hattori
    Neurological Sciences, 2021, 42 : 4767 - 4770
  • [25] Randomized double-blind placebo-controlled trial of hydrogen inhalation for Parkinson's disease: a pilot study
    Yoritaka, Asako
    Kobayashi, Yasuko
    Hayashi, Tetsuo
    Saiki, Shinji
    Hattori, Nobutaka
    NEUROLOGICAL SCIENCES, 2021, 42 (11) : 4767 - 4770
  • [26] Donepezil for dementia in Parkinson's disease: A randomized, double-blind, placebo-controlled, crossover study.
    Ravina, B
    Putt, M
    Siderowf, A
    Farrar, JT
    Gillespie, M
    Crawley, A
    Fernandez, H
    Treischmann, M
    Reichwein, S
    Simuni, T
    MOVEMENT DISORDERS, 2004, 19 (09) : 1132 - 1133
  • [27] Randomized, double-blind, placebo-controlled study of naltrexone for impulse control disorders in Parkinson's disease
    Weintraub, D.
    Xie, S. X.
    Stern, M.
    Hurtig, H.
    Siderowf, A.
    Minger, J.
    Papay, K.
    MOVEMENT DISORDERS, 2013, 28 : S141 - S142
  • [28] Mucuna pruriens therapy in Parkinson's disease: A double-blind, placebo-controlled, randomized, crossover study
    Cilia, R.
    Laguna, J.
    Cassani, E.
    Cereda, E.
    Pezzoli, G.
    MOVEMENT DISORDERS, 2015, 30 : S425 - S425
  • [29] Rotigotine transdermal patch in Chinese patients with advanced Parkinson's disease: A randomized, double-blind, placebo-controlled pivotal study
    Zhang, Zhen-Xin
    Liu, Chun-Feng
    Tao, En-Xiang
    Shao, Ming
    Liu, Yi-Ming
    Wang, Jian
    Asgharnejad, Mahnaz
    Xue, Hai-Bo
    Surmann, Erwin
    Bauer, Lars
    PARKINSONISM & RELATED DISORDERS, 2017, 44 : 6 - 12
  • [30] Efficacy of bright light therapy in perinatal depression: A randomized, double-blind, placebo-controlled study
    Donmez, Melike
    Yorguner, Nese
    Kora, Kaan
    Topcuoglu, Volkan
    JOURNAL OF PSYCHIATRIC RESEARCH, 2022, 149 : 315 - 322
12345